Acadia Healthcare Stock
Your prediction
Acadia Healthcare Stock
Pros and Cons of Acadia Healthcare in the next few years
Pros
Cons
Performance of Acadia Healthcare vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Acadia Healthcare | -2.540% | -7.258% | -25.806% | -68.750% | -68.232% | -85.256% | -70.513% |
| Ensign Group Inc. | -1.340% | -2.614% | -4.487% | 10.370% | 17.323% | - | - |
| Amn Healthcare Svs | 2.220% | -1.429% | -4.828% | -45.669% | -39.474% | -87.103% | -75.357% |
| Chemed Corp. | 1.120% | 0.556% | -5.729% | -30.385% | -27.309% | - | - |
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.Acadia Health, recognized under the US symbol in the Healthcare Providers & Services sector, presents a mixed but intriguing financial profile. A closer look at its financial statements reveals strength in certain areas, yet vulnerabilities exist that warrant attention. Overall, the numbers indicate a company grappling with several challenges while maintaining operational capabilities.
Starting with the positive aspects, Acadia Health demonstrates a notable increase in total assets over the past few years, climbing from approximately $4.77 billion in 2021 to around $5.36 billion in 2023. This growth in assets implies a robust investment strategy, positioning the company to take advantage of future opportunities within a rapidly evolving healthcare landscape. Additionally, their cash flow from operating activities also stands out, recording a strong figure of approximately $462 million for 2023, indicating efficient management of operations.
Another point of interest is Acadia Health's EBITDA margin, which is relatively healthy at around 22%. This reflects the company's solid operational efficiency concerning its income potential, making it a competitive player in the healthcare realm. With a forward PE ratio of approximately 21.10, the company is positioned well for potential future earnings growth, particularly with forecasted earnings-per-share estimates suggesting upward trends.
Comments
